Avant Technologies terminates ELOC with GHS Investments, plans new equity line with $2 floor price

AVAI BIO, INC.

Effective May 13, 2025, the company and GHS Investments mutually terminated the July 17, 2024 Equity Financing Agreement (ELOC).
Termination was based on evaluation that existing terms, including the minimum floor price, no longer aligned with business strategy.
Company will withdraw its pending Form S-1 and pursue a new ELOC with a higher minimum floor price of $2.00 per share.
Both parties confirmed no further obligations or liabilities under the terminated agreements.
New ELOC structure is intended to improve terms, compliance, and shareholder alignment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.